Literature DB >> 17287468

Visceral fat adipokine secretion is associated with systemic inflammation in obese humans.

Luigi Fontana1, J Christopher Eagon, Maria E Trujillo, Philipp E Scherer, Samuel Klein.   

Abstract

Although excess visceral fat is associated with noninfectious inflammation, it is not clear whether visceral fat is simply associated with or actually causes metabolic disease in humans. To evaluate the hypothesis that visceral fat promotes systemic inflammation by secreting inflammatory adipokines into the portal circulation that drains visceral fat, we determined adipokine arteriovenous concentration differences across visceral fat, by obtaining portal vein and radial artery blood samples, in 25 extremely obese subjects (mean +/- SD BMI 54.7 +/- 12.6 kg/m(2)) during gastric bypass surgery at Barnes-Jewish Hospital in St. Louis, Missouri. Mean plasma interleukin (IL)-6 concentration was approximately 50% greater in the portal vein than in the radial artery in obese subjects (P = 0.007). Portal vein IL-6 concentration correlated directly with systemic C-reactive protein concentrations (r = 0.544, P = 0.005). Mean plasma leptin concentration was approximately 20% lower in the portal vein than in the radial artery in obese subjects (P = 0.0002). Plasma tumor necrosis factor-alpha, resistin, macrophage chemoattractant protein-1, and adiponectin concentrations were similar in the portal vein and radial artery in obese subjects. These data suggest that visceral fat is an important site for IL-6 secretion and provide a potential mechanistic link between visceral fat and systemic inflammation in people with abdominal obesity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17287468     DOI: 10.2337/db06-1656

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  405 in total

1.  Portal vein and systemic adiponectin concentrations are closely linked with hepatic glucose and lipoprotein kinetics in extremely obese subjects.

Authors:  Faidon Magkos; Elisa Fabbrini; Bruce W Patterson; J Christopher Eagon; Samuel Klein
Journal:  Metabolism       Date:  2011-05-31       Impact factor: 8.694

Review 2.  Adipokines as novel biomarkers and regulators of the metabolic syndrome.

Authors:  Yingfeng Deng; Philipp E Scherer
Journal:  Ann N Y Acad Sci       Date:  2010-11       Impact factor: 5.691

Review 3.  Adipose tissue and inflammatory bowel disease pathogenesis.

Authors:  Christopher Fink; Iordanes Karagiannides; Kyriaki Bakirtzi; Charalabos Pothoulakis
Journal:  Inflamm Bowel Dis       Date:  2012-03-08       Impact factor: 5.325

4.  Body mass index, waist circumference, and the risk of type 2 diabetes mellitus: implications for routine clinical practice.

Authors:  Silke Feller; Heiner Boeing; Tobias Pischon
Journal:  Dtsch Arztebl Int       Date:  2010-07-02       Impact factor: 5.594

5.  Estrogenic Impact on Cardiac Ischemic/Reperfusion Injury.

Authors:  Sivaporn Sivasinprasasn; Krekwit Shinlapawittayatorn; Siriporn C Chattipakorn; Nipon Chattipakorn
Journal:  J Cardiovasc Transl Res       Date:  2016-01-19       Impact factor: 4.132

Review 6.  Nutritional models of foetal programming and nutrigenomic and epigenomic dysregulations of fatty acid metabolism in the liver and heart.

Authors:  Jean-Louis Guéant; Rania Elakoum; Olivier Ziegler; David Coelho; Eva Feigerlova; Jean-Luc Daval; Rosa-Maria Guéant-Rodriguez
Journal:  Pflugers Arch       Date:  2013-09-03       Impact factor: 3.657

7.  Fighting obesity: When muscle meets fat.

Authors:  Xin Yang; Pengpeng Bi; Shihuan Kuang
Journal:  Adipocyte       Date:  2014-12-10       Impact factor: 4.534

8.  Transcription factor 21 (TCF21) promotes proinflammatory interleukin 6 expression and extracellular matrix remodeling in visceral adipose stem cells.

Authors:  Takeshi Akama; Tae-Hwa Chun
Journal:  J Biol Chem       Date:  2018-03-14       Impact factor: 5.157

9.  In vivo analysis of γH2AX+ cells in skeletal muscle from aged and obese humans.

Authors:  Cory M Dungan; Bailey D Peck; R Grace Walton; Zhengyan Huang; Marcas M Bamman; Philip A Kern; Charlotte A Peterson
Journal:  FASEB J       Date:  2020-04-04       Impact factor: 5.191

10.  Inflammatory "adiposopathy" in major amputation patients.

Authors:  Christine R Mauro; Binh T Nguyen; Peng Yu; Ming Tao; Ian Gao; Michael A Seidman; Louis L Nguyen; C Keith Ozaki
Journal:  Ann Vasc Surg       Date:  2013-04       Impact factor: 1.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.